WIN-Partners Co., Ltd. (3183.T)
JPY 1295.0
(-1.6%)
JPY 1295.0
(-1.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.91 Billion JPY | 6.95% |
| 2022 | 3.11 Billion JPY | -12.99% |
| 2021 | 2.81 Billion JPY | 22.84% |
| 2020 | 2.44 Billion JPY | -11.13% |
| 2019 | 2.84 Billion JPY | -13.81% |
| 2018 | 3.49 Billion JPY | -5.47% |
| 2017 | 4.08 Billion JPY | 2.99% |
| 2016 | 3.31 Billion JPY | 1.72% |
| 2015 | 3.36 Billion JPY | 13.22% |
| 2014 | 2.87 Billion JPY | 5.74% |
| 2013 | 2.71 Billion JPY | 56.77% |
| 2012 | 1.73 Billion JPY | -5.77% |
| 2011 | 1.84 Billion JPY | 15.08% |
| 2010 | 1.6 Billion JPY | -3.7% |
| 2009 | 1.66 Billion JPY | 16.22% |
| 2008 | 1.54 Billion JPY | -8.47% |
| 2007 | 1.56 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 708.98 Million JPY | 97154.05% |
| 2024 Q1 | 728 Thousand JPY | -99.93% |
| 2023 Q1 | 435.07 Million JPY | -34.98% |
| 2023 Q2 | 536.95 Million JPY | 23.42% |
| 2023 Q3 | 776 Million JPY | 44.52% |
| 2023 Q4 | 959.14 Million JPY | 23.6% |
| 2023 FY | - JPY | 6.95% |
| 2022 Q3 | 694.77 Million JPY | 19.9% |
| 2022 Q1 | 529.48 Million JPY | -27.0% |
| 2022 Q2 | 579.47 Million JPY | 9.44% |
| 2022 Q4 | 669.19 Million JPY | -3.68% |
| 2022 FY | - JPY | -12.99% |
| 2021 FY | - JPY | 22.84% |
| 2021 Q4 | 725.3 Million JPY | -25.36% |
| 2021 Q1 | 535.06 Million JPY | -31.86% |
| 2021 Q2 | 640.88 Million JPY | 19.78% |
| 2021 Q3 | 971.78 Million JPY | 51.63% |
| 2020 FY | - JPY | -11.13% |
| 2020 Q2 | 542.85 Million JPY | 88.53% |
| 2020 Q3 | 639.3 Million JPY | 17.77% |
| 2020 Q4 | 785.19 Million JPY | 22.82% |
| 2020 Q1 | 287.93 Million JPY | -52.77% |
| 2019 FY | - JPY | -13.81% |
| 2019 Q4 | 609.58 Million JPY | 3.37% |
| 2019 Q3 | 589.71 Million JPY | -15.83% |
| 2019 Q2 | 700.65 Million JPY | -7.56% |
| 2019 Q1 | 757.95 Million JPY | -28.78% |
| 2018 Q1 | 565.22 Million JPY | -32.6% |
| 2018 Q3 | 644.24 Million JPY | -9.54% |
| 2018 FY | - JPY | -5.47% |
| 2018 Q2 | 712.22 Million JPY | 26.01% |
| 2018 Q4 | 1.06 Billion JPY | 65.19% |
| 2017 Q2 | 704.07 Million JPY | -11.52% |
| 2017 FY | - JPY | 2.99% |
| 2017 Q4 | 838.62 Million JPY | 3.57% |
| 2017 Q3 | 809.75 Million JPY | 15.01% |
| 2017 Q1 | 795.73 Million JPY | -4.55% |
| 2016 Q3 | 789.95 Million JPY | 6.62% |
| 2016 FY | - JPY | 1.72% |
| 2016 Q4 | 833.7 Million JPY | 5.54% |
| 2016 Q2 | 740.92 Million JPY | 6.24% |
| 2016 Q1 | 697.37 Million JPY | -21.1% |
| 2015 FY | - JPY | 13.22% |
| 2015 Q4 | 883.86 Million JPY | 1.01% |
| 2015 Q3 | 875 Million JPY | 17.06% |
| 2015 Q2 | 747.5 Million JPY | 12.41% |
| 2015 Q1 | 665 Million JPY | -21.95% |
| 2014 Q3 | 783 Million JPY | 10.52% |
| 2014 FY | - JPY | 5.74% |
| 2014 Q4 | 852 Million JPY | 8.81% |
| 2014 Q2 | 708.5 Million JPY | 40.02% |
| 2014 Q1 | 506 Million JPY | -36.59% |
| 2013 Q3 | 2 Million JPY | -99.67% |
| 2013 Q4 | 798 Million JPY | 39800.0% |
| 2013 FY | - JPY | 56.77% |
| 2013 Q1 | 379 Million JPY | -25.76% |
| 2013 Q2 | 599 Million JPY | 58.05% |
| 2012 Q4 | 510.51 Million JPY | 2.68% |
| 2012 Q3 | 497.19 Million JPY | 26.32% |
| 2012 Q1 | 333.07 Million JPY | -31.74% |
| 2012 FY | - JPY | -5.77% |
| 2012 Q2 | 393.6 Million JPY | 18.17% |
| 2011 Q4 | 487.92 Million JPY | -3.44% |
| 2011 FY | - JPY | 15.08% |
| 2011 Q1 | 407.17 Million JPY | -13.18% |
| 2011 Q2 | 440.09 Million JPY | 8.08% |
| 2011 Q3 | 505.31 Million JPY | 14.82% |
| 2010 Q1 | 362.56 Million JPY | -25.71% |
| 2010 FY | - JPY | -3.7% |
| 2010 Q2 | 363.26 Million JPY | 0.19% |
| 2010 Q3 | 404.49 Million JPY | 11.35% |
| 2010 Q4 | 468.97 Million JPY | 15.94% |
| 2009 Q3 | 438.6 Million JPY | 19.99% |
| 2009 Q2 | 365.52 Million JPY | -0.81% |
| 2009 Q4 | 488.03 Million JPY | 11.27% |
| 2009 Q1 | 368.52 Million JPY | -21.81% |
| 2009 FY | - JPY | 16.22% |
| 2008 Q2 | 256.66 Million JPY | 0.0% |
| 2008 Q4 | 471.3 Million JPY | 15.4% |
| 2008 FY | - JPY | -8.47% |
| 2008 Q3 | 408.39 Million JPY | 59.12% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| OLBA HEALTHCARE HOLDINGS, Inc. | 2.79 Billion JPY | -4.459% |
| Alfresa Holdings Corporation | 51.97 Billion JPY | 94.39% |
| Vital KSK Holdings, Inc. | 8.84 Billion JPY | 67.021% |
| MediPal Holdings Corporation | 65.31 Billion JPY | 95.535% |
| AS ONE Corporation | 12.65 Billion JPY | 76.957% |
| Yamashita Health Care Holdings,Inc. | 1.23 Billion JPY | -136.116% |
| Suzuken Co., Ltd. | 51.57 Billion JPY | 94.346% |